// App-Quantinova.ai

64 : Significant and Sustained Improvement of Health‐Related Quality of Life (HRQL) Scores in Patients with Hepatitis C (HCV) and Sustained Virologic Response (SVR)

Researchers

Presenter

  • Zobair M. Younossi

Principal Investigators

  • Maria Stepanova

  • Edward J. Gane

  • Ira Jacobson

  • David R. Nelson

  • Ashley S. Brown

  • Issah Younossi

  • Linda Henry

Medical Centers

  • Center for Liver Disease, Department of Medicine, Inova Fairfax Hospital, Falls church, Virginia, United States

  • Center for Outcomes Research in Liver Disease, Washington DC, VA

  • New Zealand Liver Transplant Unit, Auckland City Hospital, Auckland, New Zealand

  • Medicine Mt. Sinai Beth Israel, New York, NY

  • University of Florida, Cainsvillle, FL

  • Paediatric Haematology, Imperial College Healthcare NHS Trust, London,United Kingdom

Locations

  • United States

  • New Zealand

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis C

Biomarkers

  • Sustained virological response

Drug/Treatment

  • Sofosbuvir

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A